Become a Member
NJ ACTS is dedicated to leading the development of new approaches to the health problems of New Jersey and to translating those advances into therapies and treatments.
Find a Clinical Trial
Rutgers supports nearly 350 clinical trials at any given time. Our Rutgers Clinical Research Organization is the gateway to our statewide clinical trial activities
Funding Opportunities
NJ ACTS disseminates information on funding opportunities to its members and partner institutions, directly through emails and our website.
EVENTS
Child Health Institute of New Jersey Special Seminar
June 1 @ 12:00 pm - 1:00 pmChild Health Institute of New Jersey Special Seminar-Tissue-Resident Natural Killer Cells, Dorothy S...
Virtual-RWJMS Pediatric Grand Rounds
June 4 @ 8:00 am - 9:00 amRWJMS Pediatric Grand Rounds-TBA, Residents and Fellows, Robert Wood Johnson Medical School. Clinica...
NEWS
Putting A Price On COVID-19 Treatment Remdesivir
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That's when most drugs get price tags. Gilead Sciences, which makes remdesivir, is...
Rutgers Leads Clinical Trial of Drug to Prevent Cytokine Storms
Rutgers has launched a clinical trial to test the safety and efficacy of an oral anti-inflammatory drug that could help prevent serious illness and death in early-stage COVID-19 patients. The drug, EDP1815, developed by Evelo Biosciences Inc., will be given to newly...